Published in
Springer Nature [academic journals on nature.com], Bone Marrow Transplantation, 10(51), p. 1404-1407, 2016
DOI: 10.1038/bmt.2016.145
Links
Tools
The addition of ofatumumab to the conditioning regimen does not improve the outcome of patients with high-risk CLL undergoing reduced intensity allogeneic haematopoietic cell transplantation: a pilot trial from the GETH and GELLC (CLL4 trial)
Journal article published in 2016 by
P. Montesinos,
M. Cabrero,
D. Valcárcel,
M. Rovira,
J. A. García-Marco,
J. Loscertales,
C. Moreno,
R. Duarte,
M. J. Terol,
N. Villamor,
P. Abrisqueta,
D. Caballero,
J. Sanz 
,
J. Delgado
,
J. Delgado
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 